Douglas Williamson
Chief Tech/Sci/R&D Officer presso ACADIA PHARMACEUTICALS INC.
Profilo
Currently, Douglas J.
Williamson occupies the position of Executive VP, Head-Research & Development at ACADIA Pharmaceuticals, Inc. He is also Member of The Royal College of Psychiatrists.
He previously occupied the position of Chief Medical Officer at Avadel Pharmaceuticals Plc, Head-Early Phase Clinical Development Neuroscience at Eli Lilly & Co., Vice President & Global Head-Therapeutic at PAREXEL International Corp.
and Senior VP, Head-US Research & Development at H.
Lundbeck A.
Dr. Williamson received a doctorate from The University of Edinburgh.
Posizioni attive di Douglas Williamson
Società | Posizione | Inizio |
---|---|---|
ACADIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 09/01/2023 |
The Royal College of Psychiatrists
The Royal College of Psychiatrists Financial ConglomeratesFinance The Royal College of Psychiatrists is a professional body responsible for education and training, and setting and raising standards in psychiatry. The non-profit company is based in London, UK. The British company provides a guide to suicide-related information and resources on their website, as well as special interest groups for members to come together in a particular area of psychiatry. The company also has a building capacity project funded by Health Education England and focus on quality improvement to improve the quality of care delivered to patients. The information they provide is for any woman who has - or thinks she may have - perinatal OCD, as well as partners, family, and friends who want to find out more. | Corporate Officer/Principal | - |
Precedenti posizioni note di Douglas Williamson
Società | Posizione | Fine |
---|---|---|
BRIGHT MINDS BIOSCIENCES INC. | Director/Board Member | 09/01/2023 |
PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
H. LUNDBECK A/S | Corporate Officer/Principal | - |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
AVADEL PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | - |
Formazione di Douglas Williamson
The University of Edinburgh | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 5 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
ACADIA PHARMACEUTICALS INC. | Health Technology |
H. LUNDBECK A/S | Health Technology |
AVADEL PHARMACEUTICALS PLC | Health Technology |
BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
Aziende private | 2 |
---|---|
PAREXEL International Corp.
PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
The Royal College of Psychiatrists
The Royal College of Psychiatrists Financial ConglomeratesFinance The Royal College of Psychiatrists is a professional body responsible for education and training, and setting and raising standards in psychiatry. The non-profit company is based in London, UK. The British company provides a guide to suicide-related information and resources on their website, as well as special interest groups for members to come together in a particular area of psychiatry. The company also has a building capacity project funded by Health Education England and focus on quality improvement to improve the quality of care delivered to patients. The information they provide is for any woman who has - or thinks she may have - perinatal OCD, as well as partners, family, and friends who want to find out more. | Finance |